Skip to main content

AGC Pharma Chemicals is thrilled to announce its participation at CPHI Milan 2024, taking place from October 8-10. CPHI Milan unites industry leaders, pharma professionals and business of all sizes under one roof for three days of powerful connection and collaboration.

You’ll find us at Booth 5C121, where we will showcase our capabilities in Small Molecules, Intermediates development and production. Our team is eager to discuss how we can help accelerate your pharmaceutical projects, from process development to scale-up and manufacturing.

This event is the perfect opportunity to connect and explore how our expertise can add value to your API and intermediate projects. To make the most of your time at CPHI, we encourage you to schedule a meeting in advance with our experts. Let’s collaborate and bring your next innovation to the market faster and more efficiently.

Reach out to book a meeting and let’s explore new possibilities for your projects at CPHI Milan!

Latest News

AGC PharmaEvents & ConventionsAGC Pharma Chemicals at CPHI Milan 2024: Let’s talk small molecule innovation
30th September 2024

AGC Pharma Chemicals at CPHI Milan 2024: Let’s talk small molecule innovation

AGC Pharma Chemicals is thrilled to announce its participation at CPHI Milan 2024, taking place from October 8-10. CPHI Milan unites industry leaders, pharma professionals and business of all sizes under…
AGC PharmaEvents & ConventionsAGC Pharma Chemicals at NLSDays 2024
10th September 2024

AGC Pharma Chemicals at NLSDays 2024

We are delighted to announce AGC Pharma Chemicals’ participation in NLSDays 2024, scheduled for September 18th to 19th in Malmö, Sweden. The largest Nordic partnering conference dedicated to the life…
AGC PharmaResources & DevelopmentCarbon Footprint and CDMOs: How is AGC Pharma Chemicals addressing it?
24th July 2024

Carbon Footprint and CDMOs: How is AGC Pharma Chemicals addressing it?

The production of medicines, while vital for human health, leaves a substantial environmental footprint. According to the Sustainable Markets Initiative (SMI), the Biopharmacy industry is responsible for 4–5% of all…